U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865144) titled 'Effect of Rhopressa on Intraocular Pressure (IOP) in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT' on March 04.
Brief Summary: The purpose of this study is to collect data about how Rhopressa affects IOP in patients who have had an SLT procedure in both eyes.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Primary Open Angle Glaucoma or Ocular Hypertension
Intervention:
DRUG: Netarsudil ophthalmic solution 0.02%
Apply one drop in each eye every evening
DRUG: Artificial tears
Apply one drop in each eye every evening
Recruitment Status: NOT_YET_RECRUITING
Sponsor: East Coast Ins...